Other key drug-drug interactions involving inhibition of CYP3A4 are with the dihydropyridine calcium channel blockers (benidipine, azelnidipine, nifedipine), the benzene acetonitrile calcium channel blocker (verapamil), and the benzodiazepine calcium channel blocker (diltiazem) (Causevic-Ramosevac and Semiz, 2013), Table 1
Patients receiving checkpoint inhibitors should be closely monitored so that potentially life-threatening complications can be diagnosed early and treated, the authors added
That precision is a game-changer for study integrity
The influence of the gut microbiota is attributed to the host during disease, ageing, and lifestyle habits
Consistent sourcing and quality control are essential for any research protocol comparing results across multiple batches or time points.